glp 1 agonist benefits GLP-1 Receptor Agonists in Heart Failure Management GLP-1 Agonists For Obesity In
Description
Therefore, if GLP-1 RA treatment specifically increases the risk of pancreatitis in this vulnerable population, such an effect would likely remain undetected in randomized trials
Detailed considerations based on current knowledge are presented below
It can affect patients both on a psychological and physical level, with overweight and obese people found to be at risk for diabetes, cardiovascular disease, cancer, and premature death [2]
There are also reports of enhanced islet neogenesis from duct precursors (21)
doi: 10.3390/ijms25073812 [DOI] [PMC free article] [PubMed] [Google Scholar] 131.Rubin R
